Hội thảo: Cập nhật chẩn đoán và điều trị ung thư phổi không tế bào nhỏ giai đoạn tiến xa có đột biến EGFR chèn đoạn EXON 20

Dear Colleagues,

In the context of IBD being a complex chronic inflammatory disease requiring long-term, individualized treatment strategies, the workshop focuses on discussing the role of biologics and biosimilars based on international guidelines and clinical research data. Aiming to update and exchange current scientific evidence in the management of Inflammatory Bowel Disease (IBD)

NEW ACCESS OPPORTUNITIES FOR IBD PATIENTS:

ROLE OF BIOSIMILARS

Through in-depth reports and academic discussions, the program aims to support healthcare staff in enhancing decision‑making capacity, optimizing effectiveness and safety in clinical practice, thereby contributing to improving the quality of care for patients with inflammatory bowel disease in Vietnam.

If technical support is needed, dear colleagues please contact Pham Dinh Nguyen:

1. Phone 028 39525126
2. email: khoahocdaotao5@umc.edu.vn.

Sincerely announced.

SCIENTIFIC AND TRAINING DEPARTMENT

UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL, HCMC